Cancer Res Treat.  2011 Jun;43(2):83-88.

Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008

• Lee KS
• Oh DK
• Han MA
• Lee HY
• Jun JK
• Choi KS
• Park EC

Abstract

PURPOSE
The National Cancer Screening Program (NCSP) began in 1999. The objective of this report is to evaluate the results of the NCSP in 2008 and provide essential evidence associated with the gastric cancer screening program in Korea.
MATERIALS AND METHODS
Data was obtained from the National Cancer Screening Information System; participation rates in gastric cancer screening were calculated. According to screening modalities, recall rates were estimated with 95% confidence intervals (CIs).
RESULTS
The target population of the gastric cancer screening program in 2008 was 7,132,820 Korean men and women aged 40 and over, 2,076,544 of whom underwent upper endoscopy or upper gastrointestinal (UGI) series as screening tools (participation rate, 29.1%). Disparities in participation rates were observed relating to gender and health insurance type. Overall, recall rates of upper endoscopy and UGI series were 3.1% (95% CI, 3.0 to 3.1) and 33.3% (95% CI, 33.3 to 33.4), respectively.
CONCLUSION
According to our research, efforts to facilitate participation and to reduce disparities in gastric cancer screening among Korean men and women are needed. These results will provide essential data for evidence-based strategies in gastric cancer control in Korea.

Keyword

Korea; Mass screening; Stomach neoplasms

MeSH Terms

Aged
Early Detection of Cancer
Endoscopy
Female
Health Services Needs and Demand
Humans
Insurance, Health
Korea
Male
Mass Screening
Stomach Neoplasms

Figure

• 

  Fig. 1 Number of participants by health insurance type and age from the National Cancer Screening Program, 2008.

• 

  Fig. 2 Number of participants by screening modalities and age from the National Cancer Screening Program, 2008. UGI, upper gastrointestinal.

• 

  Fig. 3 Participation rates by gender and age from the National Cancer Screening Program, 2008.

• 

  Fig. 4 Participation rates by health insurance type and age from the National Cancer Screening Program, 2008.

Reference

1. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009; 41:122–131. PMID: 19809561.

2. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010; 25:1113–1121. PMID: 20676319.

3. Park CH. Proposal of a screening program for gastric cancer in Korea. J Korean Med Assoc. 2002; 45:964–971.

4. Perry N, Broeders M, de Wolf C, Tornberg S, Hölland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 2006. 4th ed. Brussels: European Communities;p. 53–54.

5. National Cancer Center. Ministry for Health Welfare and Family Affairs. Cancer facts and figures 2009. 2009. Goyang: National Cancer Center;p. 47–56.

6. Ministry of Health, Labour and Welfare [Internet]. cited 2010 May 28. Tokyo: Ministry of Health, Labour and Welfare;Available from: http://www.mhlw.go.jp/shingi/2004/04/s0427-2.html .

7. Health Statistics in Japan, 2007 [Internet]. cited 2010 May 28. Tokyo: Ministry of Health, Labour and Welfare;Available from: http://www.mhlw.go.jp/english/database/db-hss/dl/hs2007a.pdf .

8. Ministry of Health, Labour and Welfare [Internet]. cited 2010 May 28. Tokyo: Ministry of Health, Labour and Welfare;Available from: http://www.mhlw.go.jp/toukei/saikin/hw/c-hoken/06/r8.html .

9. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989; 59:954–958. PMID: 2736233.

10. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age: new results from the Swedish Two-County Trial. Cancer. 1995; 75:2507–2517. PMID: 7736395.

11. Yoon NH, Lee HY, Kwak MS, Choi KS, Jun JK, Kim MK, et al. Comparison of satisfaction with cancer screening at mobile van and static sites: National Cancer Screening Program in Korea. Jpn J Clin Oncol. 2009; 39:169–174. PMID: 19179364.

12. Hisamichi S. Screening for gastric cancer. World J Surg. 1989; 13:31–37. PMID: 2658351.

13. Kim CW, Lee SY, Moon OR. Inequalities in cancer incidence and mortality across income groups and policy implications in South Korea. Public Health. 2008; 122:229–236. PMID: 17935744.

14. Murakami R, Tsukuma H, Ubukata T, Nakanishi K, Fujimoto I, Kawashima T, et al. Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer. 1990; 65:1255–1260. PMID: 2302674.

15. Sugawara N, Hirasawa Y, Morimoto T, Sibuki S, Kogane T, Sato H, et al. An investigative report about health state of old age groups at first screening for gastric mass survey. J Gastroenterol Mass Surv. 1992; 95:184–186.

16. Fukao A, Hisamichi S, Takano A, Sugawara N. Accuracies of mass screening for gastric cancer-test sensitivity and program sensitivity. J Gatstroenterol Mass Surv. 1992; 97:59–63.

17. Sugahara N, Sibuki S, Hirasawa Y, Morimoto T. Characteristics of false negative cases. Stomach Intestine. 1991; 26:1357–1362.

18. Ishida T, Suematsu T, Oomayashi K, Takada Y, Kimura S, Suematsu C. Measurement of accuracy of stomach mass screening by population-based cancer registration. J Gastroenterol Mass Surv. 1994; 32:9–16.

19. Hattori M, Fujita M, Hosokawa O, Yamazaki S. A clinico-pathological evaluation of false negative cases in gastric cancer mass survey. J Gastroenterol Mass Surv. 1998; 36:468–475.

20. Abe S, Shibuya D, Noguchi T, Shimada T. An estimate of the false-negative rate of mass-screening for gastric carcinoma. J Gastroenterol Mass Surv. 2000; 38:475–482.

21. American Society for Gastrointestinal Endoscopy. Principles of training in gastrointestinal endoscopy. From the ASGE. Gastrointest Endosc. 1999; 49:845–853. PMID: 10343249.

22. Pentti M, Muller J, Janda M, Newman B. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia. J Gastroenterol Hepatol. 2009; 24:209–213. PMID: 18823432.

23. National Cancer Center. Development on evaluation of a comprehensive regional cancer center and operational framework for the specified regional cancer center. 0720620. 2008. Goyang: National Cancer Center;p. 160–163.